menu search

Relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023

Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body...

October 11, 2023, 8:31 am

Novo nordisk halts ozempic kidney trial. why it's bad for davita.

Novo Nordisk's Ozempic already is poised to disrupt a range of industries via its weight-loss benefits. Now it threatens companies which treat kidney ...

October 11, 2023, 7:24 am

At&t stock offers a magnificent dividend yield -- but these 2 key metrics are flashing warning signs

AT&T's return on invested capital has fallen behind its weighted average cost of capital. The company's heavy debt load and interest expenses are dest...

October 11, 2023, 5:58 am

Clsa turns overweight on indian equities on strong growth, earnings prospects

Brokerage CLSA has increased its exposure to Indian equities, citing prospects of strong economic growth, profitability and credit demand, and changed...

October 11, 2023, 5:14 am

Rspt: a strategy that could pay in the long run

Invesco S&P 500 Equal weight Technology ETF invests in technology stocks within the S&P 500 index with ...

October 11, 2023, 4:56 am

Novo nordisk to stop ozempic trial to treat renal impairment early

Denmark-based drugmaker Novo Nordisk said on Tuesday it will stop a trial studying Ozempic, its popular diabetes and weight-loss drug, to treat renal ...

October 10, 2023, 5:30 pm

Bug etf: a long-term bet on cybersecurity

The Global X Cybersecurity ETF tracks the performance of the cybersecurity sector, focusing on network security, data protection, and threat detection...

October 10, 2023, 3:12 pm

Pepsi says people are skipping meals — and it's great for business

PepsiCo says the impact of weight-loss drugs on its sales has so far been "negligible." Instead, the food and beverage giant is seeing "meals becoming...

October 10, 2023, 3:01 pm

Pepsico stock analyst talks, price hikes, weight loss drugs,

PepsiCo (PEP) released its third-quarter earnings before the bell on Tuesday. The results beat Wall Street estimates and and the company raised its ea...

October 10, 2023, 2:25 pm

Pepsico stock analyst talks, price hikes, weight loss drugs

PepsiCo (PEP) released its third-quarter earnings before the bell on Tuesday. The results beat Wall Street estimates and and the company raised its ea...

October 10, 2023, 2:25 pm

Why coca-cola stock was moving higher today

Pepsi topped estimates and raised guidance for both this year and next. The company said it had not seen an impact from weight-loss drugs like Ozempic...

October 10, 2023, 1:44 pm

Fundamentals for m&a in healthcare sector remain really strong, says guggenheim's mehta

Punit Mehta, Guggenheim Securities head of healthcare investment banking, joins 'Squawk on the Street' to discuss the healthcare M&A market, how Mehta...

October 10, 2023, 1:37 pm

Brookdale's (bkd) september 2023 occupancy volumes increase

Brookdale (BKD) has seen a continuous streak of 23 months of year-over-year increases in the weighted average occupancy level....

October 10, 2023, 12:47 pm

Ozempic and wegovy aren't affecting pepsico's business much — but this growing trend is

The new class of weight-loss drugs like Ozempic and Wegovy are having a negligible impact on PepsiCo Inc.'s snacks and beverages business, but the tre...

October 10, 2023, 12:10 pm

Pepsico doesn't 'see any impact' from weight loss drugs: cfo

PepsiCo (PEP) reported third quarter results that topped analyst estimates on both the top and bottom lines. The food and beverage company also raised...

October 10, 2023, 10:47 am

Pepsico is not seeing the impact of weight-loss drugs on sales: cfo johnston

PepsiCo Inc (NASDAQ: PEP) opened slightly down on Tuesday even though it reported market-beating results for its fiscal third quarter. PepsiCo also is...

October 10, 2023, 10:05 am

Cardiol therapeutics says study results show positive effects of subcutaneously administered cannabidiol

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) has reported positive study results showing that cannabidiol, the active pharmaceutical ingredient in the...

October 10, 2023, 8:15 am

Close your equity hedge and go overweight european stocks, says deutsche bank

European bourses rallied hard Tuesday, as Deutsche Bank recommended closing its hedge on equity exposure and going overweight stocks....

October 10, 2023, 7:47 am

Should you still buy the nasdaq's best-performing september stocks?

Global Foundries could benefit from AI-driven demand for chips. Amgen has some weight-loss drugs in the pipeline that could boost the bottom line....

October 10, 2023, 6:53 am

Is it time to buy the apple downgrade dip?

Apple (NASDAQ: AAPL ) got the wind knocked out of its sails last week when KeyBanc Capital Markets analyst Brandon Nispel downgraded AAPL stock from O...

October 9, 2023, 11:15 pm


Search within

Pages Search Results: